Reza Elahi
Zanjan University of Medical Sciences
H-index: 11
Asia-Iran
Top articles of Reza Elahi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Analysis of the Current, Past, and Future Evolution of COVID-19 | Reza Elahi Parsa Karami Mahsa Bazargan Shahrzad Ahmadi Arash Azhideh | 2023/12/1 | |
Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches | Shahrzad Ahmadi Mahsa Bazargan Reza Elahi Abdolreza Esmaeilzadeh | 2023/4/1 | |
Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19) | Reza Elahi Salar Hozhabri Amirhosein Moradi Amir Siahmansouri Armin Jahani Maleki | 2023/11/2 | |
Chimeric Antigen Receptor (CAR) T cell immunotherapy for solid tumors | Abdolreza Esmaeilzadeh Davood Jafari Reza Elahi Mahsa Bazargan Maryam Zare Rafie | 2023/3/12 | |
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches | Reza Elahi Mahdis Nazari Vahid Mohammadi Kimia Esmaeilzadeh Abdolreza Esmaeilzadeh | 2023/8/4 | |
Immune Gene Therapy of Cancer | Esmaeilzadeh A. Jafari D. Ghaebi | 2023/3 | |
The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology | Abdolreza Esmaeilzadeh Vahid Mohammadi Reza Elahi Negin Rezakhani | 2023/7/23 | |
Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors | Abdolreza Esmaeilzadeh Kaveh Hadiloo Marjan Jabbari Reza Elahi | 2023/12/23 | |
Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches | Abdolreza Esmaeilzadeh Vahid Mohammadi Reza Elahi | 2023/7 | |
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis | Mahsa Bazargan Reza Elahi Abdolreza Esmaeilzadeh | 2022/7 | |
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19) | Reza Elahi Parsa Karami Amir Hossein Heidary Abdolreza Esmaeilzadeh | 2022/4/1 | |
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks | Abdolreza Esmaeilzadeh Armin Jahani Maleki Amirhosein Moradi Amir Siahmansouri Mohammad Javad Yavari | 2022/10/3 | |
Endocrine and metabolic complications of COVID-19: lessons learned and future prospects | Abdolreza Esmaeilzadeh Reza Elahi Amir Siahmansouri Armin Jahani Maleki Amirhosein Moradi | 2022/7/1 | |
Benign Cerebral Edema and Increased Intracranial Pressure (ICP) as manifestations of COVID-19 reinfection; A case report | J Clin Lab Med | A Heidary R Elahi M Nazari | 2021 |
Chimeric antigen receptor-engineered natural killer (CAR NK) cells in cancer treatment; recent advances and future prospects | Reza Elahi Amir Hossein Heidary Kaveh Hadiloo Abdolreza Esmaeilzadeh | 2021/12 | |
IL-38 as an early predictor of the ischemic stroke prognosis | Cytokine | Maryam Zare Rafie Abdolreza Esmaeilzadeh Abdolreza Ghoreishi Safa Tahmasebi Elham Faghihzadeh | 2021/10/1 |
Immune-based therapy for COVID-19 | Abdolreza Esmaeilzadeh Davood Jafari Safa Tahmasebi Reza Elahi Elnaz Khosh | 2021/5/11 | |
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview | Abdolreza Esmaeilzadeh Reza Elahi | 2020/10/26 | |
Clinical applications of interleukin-37; as a key player in the immunopathogenesis of immune disorders | Elnaz Khosh Nazila Bahmaie Reza Elahi Abdolreza Esmaeilzadeh | 2020/6/29 | |
Programmable and multi‑targeted CARs: a new breakthrough in cancer CAR‑T cell therapy | Clinical and translational oncology | S Tahmasebi R Elahi E Khosh A Esmaeilzadeh | 2020 |
Co-Authors
